Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center
NCT00736008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2011-08-26
Summary
The study will assess the clinical and laboratory data of about 100 pediatric patients diagnosed and treated at the Pediatric Hematology Unit during the years 1980 until 2007 because of thrombotic events.
The results, the treatment given, and the outcome of the patients will be summarized.
Conditions
Interventions
- OTHER
-
Observational
Data summary only
Sponsors & Collaborators
-
HaEmek Medical Center, Israel
lead OTHER
Principal Investigators
-
Carina Levin, MD · Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
-
Ayala Mari, Student · Pediatric Dpt B - Ha'Emek Medical Center - Afula - Israel
Eligibility
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2009-08-31
- Completion
- 2009-08-31
Countries
- Israel
Study Locations
More Related Trials
-
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
NCT01198717 ·Status: COMPLETED
-
Thrombocytopathy in Gaucher Disease Patients
NCT01344096 ·Status: UNKNOWN
-
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
NCT00039858 ·Status: COMPLETED ·Phase: PHASE4
-
Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
NCT01520909 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)
NCT05419648 ·Status: COMPLETED
-
Milk-only Lactation Study for Patients on Eltrombopag
NCT01055600 ·Status: WITHDRAWN ·Phase: PHASE4
-
Bleeding In Thrombocytopenia Explained
NCT03505086 ·Status: RECRUITING
-
Efficacy of a Personalized Caplacizumab Regimen Based on ADAMTS13 Activity Monitoring in Adult aTTP
NCT04720261 ·Status: TERMINATED ·Phase: PHASE2
-
Pathogen Reduction Evaluation & Predictive Analytical Rating Score
NCT02783313 ·Status: COMPLETED ·Phase: NA
-
NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults
NCT01172015 ·Status: COMPLETED ·Phase: NA
-
Management of Children With Persistent ITP, A Novel Approach
NCT07068126 ·Status: RECRUITING ·Phase: NA
-
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
NCT03025698 ·Status: COMPLETED ·Phase: PHASE2
-
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
NCT06070350 ·Status: RECRUITING ·Phase: PHASE3
-
Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms
NCT03599700 ·Status: UNKNOWN
-
Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma
NCT00151866 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure
NCT02912884 ·Status: COMPLETED
-
Childhood Reactive Thrombocytosis
NCT01230528 ·Status: COMPLETED
-
Primary Thrombocythaemia 1 Trial
NCT00175838 ·Status: COMPLETED ·Phase: NA
-
Eltrombopag in Chronic ITP
NCT04102033 ·Status: UNKNOWN ·Phase: PHASE4
-
Platelet Products Tested With the ThromboLUX® Platelet Quality Test
NCT02158416 ·Status: COMPLETED
-
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
NCT03939637 ·Status: COMPLETED ·Phase: PHASE3
-
ADAMTS13 in Thrombotic Thrombocytopenic Purpura
NCT00426686 ·Status: COMPLETED
-
Strategies for Transfusion of Platelets (SToP)
NCT00420914 ·Status: TERMINATED ·Phase: PHASE3
-
Thrombopoietin Levels and Platelet Transfusion in Neonates
NCT00549484 ·Status: COMPLETED
-
SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications
NCT04539678 ·Status: COMPLETED